Posted on September 15, 2014
It’s a fact: 72% of women report being up-to-date on their breast health screenings while only a little more than half could say the same about colon cancer. Colon cancer screening tests save lives – just like breast exams and mammograms.
We’re getting a little cheeky with our Screen This Too! campaign this October, and we need you to be part of the movement and help spread the word! Read more
Posted on August 27, 2014
One of our partners is conducting a research project about metastatic colon cancer survivor and caregiver experiences. They are looking to interview stage IV survivors and caregivers (via video/phone and in person) to learn about your clinical experience and how the disease has impacted your life. Compensation is up to $150 for your time. Read more
Posted on August 26, 2014
We’re excited to share with you a brand-spankin’-new partnership with OncLive! This reputable oncology news outlet focuses on medical news and provides oncology professionals, like oncologists, nurse practitioners, nurse navigators and nursing medical students, with the resources and information they need to provide the best patient care. In addition to their news site, OncLive stewards two publications – Oncology Nursing News and Oncology Live, which reach nearly 45,000 oncology nurses and oncologists. Read more
Posted on August 15, 2014
This week, the U.S. Food and Drug Administration (FDA) approved Cologuard, the first stool-based colon screening test that detects the presence of blood and altered DNA that may indicate certain kinds of abnormal growths related to colon cancer or precursors to cancer. In a study of 10,000 people of average risk for colon cancer, Cologuard reportedly was able to accurately detect cancer 92% of the time when it was present in an individual’s body. Read more
Posted on August 4, 2014
“It isn’t cancer, is it?” asked David Prochnow to his doctor, half-jokingly. He was 35 at the time – healthy, active and happily married with two young children.
Before his doctor could respond, David knew. His worst fears were confirmed a few days later – stage III colorectal cancer. But David’s not alone -– nearly 15,000 people under age 50 are diagnosed every year. Read more